World Journal of Pediatrics

, Volume 13, Issue 1, pp 76–83 | Cite as

Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?

  • Hoi Yan Tong
  • Nicolás Medrano
  • Alberto Manuel Borobia
  • José Antonio Ruiz
  • Ana María Martínez
  • Julia Martín
  • Manuel Quintana
  • Santos García
  • Antonio José Carcas
  • Elena Ramírez
Original article

Abstract

Background

There are few data on hepatotoxicity induced by acute or chronic paracetamol poisoning in the pediatric population. Paracetamol poisoning data can reveal the weaknesses of paracetamol poisoning management guidelines.

Methods

We retrospectively studied the patients of less than 18 years old with measurable paracetamol levels, who were brought to the emergency department (ED) of La Paz University Hospital, Madrid, Spain, for suspected paracetamol overdoses between 2005 and 2010.

Results

Ninety-two patients with suspected paracetamol poisoning were identified. In 2007, the incidence of paracetamol poisoning in the pediatric population was 0.8 [Poisson-95% confidence interval (CI): 0.03-3.69] per 10 000 inhabitants aged less than 18 years. The incidence in the same year was 1.53 (Poisson-95% CI: 0.24-5.57) per 10 000 patients in the pediatric ED. The most common cause of poisoning was attempted suicide (47.8%) in teenagers with a median age of 15 years, followed by accidental poisoning (42.2%) in babies with a median age of 2.65 years. Difference was seen in the frequency of hepatotoxicity between acute and chronic poisoning cases. Only 1 of 49 patients with acute poisoning showed hepatotoxicity [acute liver failure (ALF)], whereas 7 of 8 patients with chronic poisoning showed hepatotoxicity (3 cases of ALF). The average time to medical care was 6.83 hours for acute poisoning and 52.3 hours for chronic poisoning (P<0.001).

Conclusions

Chronic paracetamol poisoning is a potential risk factor for hepatotoxicity and acute liver failure. Delays in seeking medical help might be a contributing factor. Clinicians should have a higher index of clinical suspicion for this entity.

Key words

acute liver failure hepatotoxicity paracetamol poisoning 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

We are grateful to ServingMed.com for the corrections to the English grammar and the academic style of the manuscript.

References

  1. 1.
    Buckley N, Eddleston M. Paracetamol (acetaminophen) poisoning. Clin Evid 2007;12:2101.Google Scholar
  2. 2.
    Caravati EM. Unintentional acetaminophen ingestion in children and the potential for hepatotoxicity. J Toxicol Clin Toxicol 2000;38:291–296.PubMedGoogle Scholar
  3. 3.
    Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children and adults. Clin Pharmacol Ther 1976;19:284–294.CrossRefPubMedGoogle Scholar
  4. 4.
    Ji P, Wang Y, Li Z, Doddapaneni S, Hertz S, Furness S, et al. Regulatory review of acetaminophen clinical pharmacology in young pediatric patients. J Pharm Sci 2012;101:4383–4389.CrossRefPubMedGoogle Scholar
  5. 5.
    Burillo G, Munné P, Dueñas A, Trujillo M, Jiménez A, Adrián M, et al. Acute poisoning: epidemiological and clinical profile, and analysis techniques used in digestive decontamination used in the Spanish Emergency Services in 2006-Study-HISPATOX. Emergencias 2008;20:15–26. [In Spanish]Google Scholar
  6. 6.
    Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652–658.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sabaté M, Ibáñez L, Pérez E, Vidal X, Buti M, Xiol X, et al. Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol 2011;11:80.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Pershad J, Nichols M, King W. “The silent killer”: chronic acetaminophen toxicity in a toddler. Pediatr Emerg Care 1999;15:43–46.CrossRefPubMedGoogle Scholar
  9. 9.
    Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatotoxicity after multiple doses in children. J Pediatr 1998;132:22–27.CrossRefPubMedGoogle Scholar
  10. 10.
    Kozer E, Greenberg R, Zimmerman D, Berkovitch M. Repeated supratherapeutic doses of paracetamol in children–a literature review and suggested clinical approach. Acta Paediatr 2006;95:1165–1171.CrossRefPubMedGoogle Scholar
  11. 11.
    Alander SW, Dowd MD, Bratton SL, Kearns GL. Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med 2000;154:346–350.CrossRefPubMedGoogle Scholar
  12. 12.
    Woo OF, Mueller PD, Olson KR, Anderson IB, Kim SY. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 2000;35:363–368.CrossRefGoogle Scholar
  13. 13.
    Singer AJ, Carracio TR, Mofenson HC. The temporal profile of increased transaminase levels in patients with acetaminopheninduced liver dysfunction. Ann Emerg Med 1995;26:49–53.CrossRefPubMedGoogle Scholar
  14. 14.
    James LP, Wells E, Beard RH, Farrar HC. Predictors of outcome after acetaminophen poisoning in children and adolescents. J Pediatr 2002;140:522–526.CrossRefPubMedGoogle Scholar
  15. 15.
    Yang R, Miki K, He X, Killeen ME, Fink MP. Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009;13:55.CrossRefGoogle Scholar
  16. 16.
    Sobradillo B, Aguirre A, Aresti U, Bilbao C, Fernández-Ramos C, Lizárraga A, et al. Growth curves and tables (longitudinal and transversal study), 1st ed. Bilbao, Spain: Fundación Faustino Orbegozo Eizaguirre, 2004: 11–21.Google Scholar
  17. 17.
    Noguera A, Martínez L, Luaces C. Acetaminophen poisoning. In: Mintegi S, Grupo de Trabajo de Intoxicaciones de la SEUP. Handbook of poisoning in Pediatrics, 2nd ed. Ergon: Madrid, 2008: 135–143.Google Scholar
  18. 18.
    Daly F, Fountain JS, Murray L, Graudins A, Buckley NA. Panel of Australian and New Zesland clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2008;118:296–301.Google Scholar
  19. 19.
    CDER-PHRMA-AASLD Conference, 2000, clinical white paper, preconference study document before conference “Drug-Induced Liver Injury: A National and Global Problem.” http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/ucm091457.pdf (accessed December 23, 2014).Google Scholar
  20. 20.
    Jiménez-Gómez J, Polo-Miquel B, Donat-Aliaga E. Acute hepatic failure. In: Spanish Society of Gastroenterology, Hepatology and Pediatric Nutrition, eds. Diagnostic-therapeutic protocols of gastroenterology, hepatology and nutrition pediatric, 1st ed. Madrid, Spain: ERGON, 2010: 197–205.Google Scholar
  21. 21.
    Capellá D, Laporte JR. La notificación espontánea de reacciones adversas a medicamentos. In: Laporte JR, Tognoni G. Principios de Epidemiología del Medicamento. Barcelona: Masson-Salvat, 1993: 147–170. [In Spanish]Google Scholar
  22. 22.
    Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006;15:398–405.CrossRefPubMedGoogle Scholar
  23. 23.
    Azkunaga B, Mintegi S, Del Arco L, Bizkana I, grupo de trabajo de intoxicaciones, Sociedad Española de urgencias de Pediatría. Epidemiological changes in poisonings treated in emergency pediatric services Spaniards between 2001 and 2010: Increase in alcohol intoxication. Emergencias 2012;24:376–379. [In Spanish]Google Scholar
  24. 24.
    Mintegi S, Fernández A, Alustiza J, Canduela V, Mongil I, Caubet I, et al. Emergency visits for childhood poisoning: a 2-year prospective multicenter survey in Spain. Pediatr Emerg Care 2006;22:334–338.CrossRefPubMedGoogle Scholar
  25. 25.
    Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D. Drug-related hepatotoxicity and acute liver failure. J Pediatr Gastroenterol Nutr 2008;47:395–405.CrossRefPubMedGoogle Scholar
  26. 26.
    Escorsell A, Mas A, De la Mata M, Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases. Liver transpl 2007;13:1389–1395.CrossRefPubMedGoogle Scholar
  27. 27.
    Mahadevan SBK, McKiernan PJ, Davies P, Kelly DA. Paracetamol induced hepatotoxicity. Arch Dis Child 2006;91:598–603.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Spanish Agency for Medicines and Health Products. Intravenous (IV) paracetamol: Cases of dosing error. Spanish Agency for Medicines and Health Products (AEMPS). Information note MUH (FV), 05/2012, 2012. http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2012/NI-MUH_05–2012.htm (accessed December 23, 2014).Google Scholar
  29. 29.
    Whyte IM, Francis B, Dawson AH. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin 2007;23:2359–2368.CrossRefPubMedGoogle Scholar
  30. 30.
    Kerr F, Dawson A, Whyte IH, Buckley N, Murray L, Graudins A, et al. The australasian clinical toxicology investigators collaboration. Randomized trial of different loading infusion rates of N-acetylcystine. Ann Emerg Med 2005;45:402–408.CrossRefPubMedGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Hoi Yan Tong
    • 1
  • Nicolás Medrano
    • 1
  • Alberto Manuel Borobia
    • 1
  • José Antonio Ruiz
    • 2
  • Ana María Martínez
    • 3
  • Julia Martín
    • 2
  • Manuel Quintana
    • 3
  • Santos García
    • 2
  • Antonio José Carcas
    • 1
  • Elena Ramírez
    • 4
  1. 1.Department of Clinical PharmacologyHospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de MadridMadridSpain
  2. 2.Pediatric Emergency DepartmentHospital Universitario La Paz, IdiPAZMadridSpain
  3. 3.General Emergency DepartmentHospital Universitario La Paz, IdiPAZMadridSpain
  4. 4.Department of Clinical PharmacologyHospital Universitario La Paz, IdiPAZ, School of Medicine, Universidad Autónoma de MadridMadridSpain

Personalised recommendations